New gel treatment for vaginal creation in MRKH syndrome
Part of Women’s health & pregnancy clinical trials.
This trial tests a new gel-like material to create a vagina in women with MRKH syndrome, avoiding the need for surgery. It may offer a simpler, less invasive option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with MRKH syndrome.
- You have not had any prior surgery or treatment to create a vagina.
- You are between 18 and 35 years old.
- You are willing to sign a consent form and follow the study plan.
- You do not have diabetes or an immune system disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at the clinical and imaging details of MRKH syndrome, a condition present from birth affecting the uterus and vagina. It aims to improve understanding and care for those with this condition.
This study tests whether transplanting a uterus from a living related donor can be done safely and can help patients with MRKH type I achieve pregnancy. It also checks risks and safety issues for both the donor and recipient.
This trial tests whether receiving a uterus transplant can allow someone with uterine absence to carry a pregnancy. It also looks at whether the procedure is safe for the patient and supports a future baby using frozen embryos.
This study tracks quality of life and follow-up care in women with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, a condition where the uterus and upper vagina are underdeveloped or absent. It compares their experiences to women without MRKH to improve care.
This trial tests a new material made from donated human tissue to repair pelvic organ prolapse. It may help women with certain types of prolapse who have not had prior pelvic surgery.
This Phase 1 study tests a vaginal implant/reconstruction device for people born with a missing or closed-off vagina. The goal is to check safety and how well the implanted vaginal tissue construct works over follow-up visits.
Hear when a new Mayer Rokitansky Kuster Hauser Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.